{Reference Type}: Case Reports
{Title}: Family hyperaldosteronism type I: a clinical case and review of literature.
{Author}: Chikladze NM;Favorova OO;Chazova IE;
{Journal}: Ter Arkh
{Volume}: 90
{Issue}: 9
{Year}: Sep 2018 20
{Factor}: 0.45
{DOI}: 10.26442/terarkh2018909115-122
{Abstract}: Family hyperaldosteronism type I (glucocorticoids-remediable hyperaldosteronism) is a rare form of symptomatic arterial hypertension (AH), which often leads to the development of cerebrovascular complications. The disease is caused by the formation of the chimeric gene CYP11B2/CYP11B1.  Expression of the chimeric gene is regulated by adrenocorticotropic hormone, and glucocorticoid therapy leads to a decrease in aldosterone secretion and normalization of blood pressure. The article presents the first clinical case of this monogenic disease diagnosed by us in Russia. The features of clinical course and treatment of the patient have been traced in the dynamics for 40 years of observation. Modern approaches to the diagnosis and treatment of this rare family form of hypertension are discussed.